Академический Документы
Профессиональный Документы
Культура Документы
National Institute of Pharmaceutical Education and ResearchHyderabad, Balanagar, Hyderabad500 037, Telanagana, India
d
To cite this article: Rukaiyya Sirajuddin Khan, Mahibalan Senthi, Poorna Chandra Rao, Ameer
Basha, Mallika Alvala, Dinesh Tummuri, Hironori Masubuti, Yoshinori Fujimoto & Ahil Sajeli Begum
(2014): Cytotoxic constituents of Abutilon indicum leaves against U87MG human glioblastoma cells,
Natural Product Research: Formerly Natural Product Letters, DOI: 10.1080/14786419.2014.976643
To link to this article: http://dx.doi.org/10.1080/14786419.2014.976643
This article may be used for research, teaching, and private study purposes. Any
substantial or systematic reproduction, redistribution, reselling, loan, sub-licensing,
systematic supply, or distribution in any form to anyone is expressly forbidden. Terms &
Conditions of access and use can be found at http://www.tandfonline.com/page/termsand-conditions
SHORT COMMUNICATION
Cytotoxic constituents of Abutilon indicum leaves against U87MG human
glioblastoma cells
Rukaiyya Sirajuddin Khana, Mahibalan Senthia, Poorna Chandra Raoa, Ameer Bashab,
Mallika Alvalac, Dinesh Tummuric, Hironori Masubutid, Yoshinori Fujimotod and Ahil
Sajeli Beguma*
The study was aimed to identify cytotoxic leads from Abutilon indicum leaves for
treating glioblastoma. The petroleum ether extract, methanol extract (AIM),
chloroform and ethyl acetate sub-fractions (AIM-C and AIM-E, respectively) prepared
from AIM were tested for cytotoxicity on U87MG human glioblastoma cells using 3(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay. These extracts
exhibited considerable activity (IC50 values of 42.6 64.5 mg/mL). The most active
AIM-C fraction was repeatedly chromatographed to yield four known compounds,
methyl trans-p-coumarate (1), methyl caffeate (2), syringic acid (3) and pinellic acid
(4). Cell viability assay of 1 4 against U87MG cells indicated 2 as most active (IC50
value of 8.2 mg/mL), whereas the other three compounds were much less active.
Interestingly, compounds 1 4 were non-toxic towards normal human cells (HEK-293).
The content of 2 in AIM-C was estimated as 3% by HPLC. Hence, presence of some
more active substances besides methyl caffeate (2) in AIM-C is anticipated.
Keywords: Abutilon indicum; MTT; U87MG; methyl caffeate; cytotoxicity;
Malvaceae
1. Introduction
Glioblastoma, a life-threatening malignant brain tumour is one of the leading causes of cancerrelated deaths among children and adults. The average life of patients with this aggressive
disease is being reported to be less than 15 months while under treatments such as surgery,
radiotherapy and chemotherapy (Tabatabai et al. 2011). Glioblastoma cells are rapidly
proliferative invading the surrounding normal brain tissue and thereby affecting spine as well.
Due to frequent acquisition of drug-resistant phenotypes and occurrence of secondary
malignancies by glioblastoma cells, the existing chemotherapy could not be effective (Liu et al.
2006; Sakariassen et al. 2007). Hence, there is a need for developing new drugs for the treatment
of glioblastoma. In view of this, this study was aimed to discover cytotoxic leads from a
commonly available plant source that inhibit brain tumour cell proliferation.
Abutilon indicum (Malvaceae), a medicinally important shrub, was selected for the study,
since its cytotoxic properties were previously reported (see later sections). It is well known as
Atibala in Hindi and found in outer Himalayan tracts from Jammu to Bhutan up to an elevation
of 1500 m and extending throughout northern and central India (Rajurkar et al. 2009). A. indicum
is used by different tribal and ethnic groups of India, Malaysia, islands of the Philippines and
Indochina for various medicinal purposes as anti-inflammatory, febrifuge, anthelmintic,
antiemetic, uterine disorders, piles and lumbago (Chopra & Chopra 1958; Chatterjee & Prakash
1991; Nadakarni 1995). Conventionally, the plant is used in inflammation, gonorrhoea treatment
and as immune stimulant (Kirtikar & Basu 1980; Khadabadi & Bhajipale 2010). Previous
phytochemical studies on this plant led to the isolation of more than 40 compounds including
phenolic compounds, alkaloids, flavonoids, steroids and terpenoids (Gaind & Chopra 1976; Kuo
et al. 2008; Pandey et al. 2011; Rajput & Patel 2012). Our study to identify natural cytotoxic
leads from the leaves of A. indicum using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide (MTT) assay is described in this communication. The study resulted in the isolation and
characterisation of methyl caffeate as an active constituent from the leaf extract.
100
% Growth Inhibition
AIP
AIM
AIM-C
AIM-E
80
60
40
20
0
10
20
30
40
Concentration in g/ml
50
% Growth Inhibition
40
20
0
0.6
1.2
2.4
4.8
9.7
Concentration in g/ml
Figure 2. Effect of methyl caffeate (2) on U87MG cell line treated for 72 h.
parallel to the present result. This article describes the first isolation of methyl caffeate (2) from
A. indicum, although caffeic acid was previously characterised from this plant (Rajput & Patel
2012). Cytotoxic properties of 2 against various cell lines such as non-small cell lung
adenocarcinoma, ovarian cells, skin melanoma, colon cancer cells (Chang et al. 2009), NCIH187 (Vongvanich et al. 2006) and human leukaemia (Lee et al. 2001) had been established.
Syringic acid (3) had been previously isolated from malvaceous plants (Althaea officinalis and
Sida acuta) (Kirtikar & Basu 1980). Synthetic syringic acid esters such as syringic acid benzyl
ester were reported to show selective dose-dependent anti-mitogenic effect against human
malignant melanoma cell lines HTB66 and HTB68 (Orabi et al. 2013). Isolation of pinellic acid
(4) from the family of Malvaceae is reported for the first time, although it had been reported from
several other families such as Pinellia ternata (Araceae) (Nagai et al. 2002) and Ulmus
davidiana var. japonica (Ulmaceae) (Choi et al. 2013).
3. Conclusion
The study demonstrated cytotoxic effect of A. indicum leaf extracts on U87MG human
glioblastoma cells. Further investigation resulted in the isolation and characterisation of methyl
caffeate as one of the active principle associated with the activity of AIM-C fraction from the
leaves. In addition, the content of methyl caffeate in the AIM-C fraction was analysed to be
approximately 3% (w/w) by HPLC. The findings indicated that methyl caffeate accounted for
approximately one-sixth of the activity that was shown by AIM-C. It is thus suggested that there
exist more minor and more active constituents in AIM-C besides methyl caffeate and/or the
observed activity of AIM-C was exerted by synergetic effect of several constituents. Methyl
caffeate (2) can be used as a pharmacophore for designing more potent analogues for treating
glioblastoma. In this context, it is interesting to note that synthetic propyl and octyl esters of
caffeic acid had been tested for cytotoxicity (IC50 values of 12 and 70 mM) against HeLa
malignant cells (Fiuza et al. 2004), and phenethyl caffeate had been reported to exhibit
significant cytotoxicity (IC50 value of 0.8 mM) against glioma stem cells (Hothi et al. 2012).
Further scale-up bioassay-guided investigations focusing on AIM-C is highly awaited.
Supplementary material
Experimental details relating to this article are available online, alongside Table S1.
Acknowledgements
One of the authors (R.S.K) is thankful to the University Grants Commission, New Delhi, India for Maulana
Azad National Fellowship for carrying research.
Funding
The authors gratefully acknowledge the financial support by the BITS-Research Initiation Grant for this
work.
References
Chang SW, Lee IK, Ryu SY. 2009. Phytochemical constituents of Bistorta manshuriensis. Nat Prod Sci. 15:234240.
Chatterjee A, Prakash C. 1991. The treatise on Indian medicinal plants. New Delhi: Publication & Information
Directorate.
Choi HG, Park YM, Lu Y, Chang HW, Na M, Lee SH. 2013. Inhibition of prostaglandin D2 production by trihydroxy
fatty acids isolated from Ulmus davidiana var. japonica. Phytother Res. 27:13761380.
Chopra RN, Chopra IC. 1958. Indigenous drugs of India. Calcutta: Academic Publishers, Dhur & Sons Pvt. Ltd.
Fiuza SM, Gomes C, Teixeira J, Girao-da-Cruz MT, Cordeiro MNDS, Milhazes N, Borgesa F, Marques MPM. 2004.
Phenolic acid derivatives with potential anticancer properties a structureactivity relationship study. Part 1:
methyl, propyl and octyl esters of caffeic and gallic acids. Bioorg Med Chem. 12:35813589.
Gaind KN, Chopra KS. 1976. Phytochemical investigation of Abutilon indicum. Planta Med. 30:174185.
Guzman JD, Mortazavi PN, Munshi T, Evangelopoulos D, McHugh TD, Gibbons S, Malkinson J, Bhakta S. 2014. 2Hydroxy-substituted cinnamic acids and acetanilides are selective growth inhibitors of Mycobacterium
tuberculosis. Med Chem Commun. 5:4750.
Hothi P, Martins TJ, Chen L, Deleyrolle L, Yoon JG, Reynolds B, Foltz G. 2012. Inhibitor of human glioblastoma stem
cells. Oncotarget. 3:11241136.
Khadabadi SS, Bhajipale NS. 2010. A review on some important medicinal plants of Abutilon spp. Res J Pharm Biol
Chem Sci. 1:718 729.
Kirtikar KR, Basu BD. 1980. Indian medicinal plants. Vol. 1. 2nd ed. New Delhi: M/S Periodical Experts; p. 314 315.
Kuo PC, Yang ML, Wu PL, Shih HN, Thang TD, Dung NX, Wu TS. 2008. Chemical constituents from Abutilon indicum.
J Asian Nat Prod Res. 10:689693.
Lee HJ, Khan M, Kang HY, Choi DH, Parkm MJ, Lee HJ. 2010. Rare natural products from the wood of Magnolia
grandiflora. Chem Nat Compd. 46:289290.
Lee SP, Jun G, Yoon EJ, Park S, Yang CH. 2001. Inhibitory effect of methyl caffeate on Fos-Jun-DNA complex
formation and suppression of cancer cell growth. Bull Korean Chem Soc. 22:11311135.
Liu G, Black KL, Yu JS. 2006. Sensitization of malignant glioma to chemotherapy through dendritic cell vaccination.
Expert Rev Vaccin. 5:233 247.
Muhit MA, Apu AS, Islam MS, Ahmed M. 2010. Cytotoxic and antimicrobial activity of the crude extract of Abutilon
indicum. Int J Pharmacogn Phytochem Res. 2:1 4.
Nadakarni AK. 1995. Indian materia medica. Bombay: Popular Prakashan (Pvt) Ltd.
Nagai T, Kiyohara H, Munakata K, Shirahata T, Sunazuka T, Harigaya Y, Yamada H. 2002. Pinellic acid from the tuber
of Pinellia ternata Breitenbach as an effective oral adjuvant for nasal influenza vaccine. Int Immunopharmacol.
2:11831193.
Orabi KY, Abaza MS, El-Sayed KA, Elnagar AY, Al-Attiyah R, Guleri RP. 2013. Selective growth inhibition of human
malignant melanoma cells by syringic acid-derived proteasome inhibitors. Cancer Cell Int. 13:8297.
Pandey DP, Rather MA, Natutiyal DP, Bachheti RK. 2011. Phytochemical analysis of Abutilon indicum. Int J Chem Tech
Res. 3:642645.
Rajput AP, Patel MK. 2012. Chemical investigation and biological activity of phytoconstituents from methanol extract of
Abutilon indicum leaves. J Chem Pharm Res. 4:39593965.
Rajurkar R, Jain R, Matake N, Aswar P, Khadbadi SS. 2009. Anti-inflammatory action of Abutilon indicum (L.) sweet
leaves by HRBC membrane stabilization. Res J Pharm Technol. 2:415416.
Sakariassen PO, Immervoll H, Chekenya M. 2007. Cancer stem cells as mediators of treatment resistance in brain tumors:
status and controversies. Neoplasia. 9:882 892.
Sunnam SK, Prasad KR. 2013. Total synthesis of ( )-pinellic acid. Synthesis. 45:19911996.
Tabatabai G, Wick W, Weller M. 2011. Stem cell-mediated gene therapies for malignant gliomas: a promising targeted
therapeutic approach? Discovery Med. 11:529536.
Tip-Pyang S, Limpipatwattana Y, Khumkratok S, Siripong P, Sichaem J. 2010. A new cytotoxic 1-azaanthraquinone
from the stems of Goniothalamus laoticus. Fitoterapia. 81:894896.
Touafek O, Kabouche Z, Brouard I, Barrera BJ. 2011. Flavonoids of Campanula alata and their antioxidant activity.
Chem Nat Compd. 46:968970.
Vongvanich N, Kittakoop P, Charoenchai P, Intamas S, Sriklung K, Thebtaranonth Y. 2006. Antiplasmodial,
antimycobacterial, and cytotoxic principles from Camchaya calcarea. Planta Med. 72:14271430.